EP-Link has been selected as a “Top Clinical Trials and New Drug Development Solution in APAC 2026” by Pharma Tech Outlook APAC, an industry publication covering the pharmaceutical and healthcare sectors across the Asia-Pacific region. The company has also been featured on the cover and in a special article of the magazine.
The feature highlights EP-Link’s clinical trial support system, the comprehensive capabilities of its specialized professionals, and its initiatives to support increasingly complex clinical trials.
Details are available via the links below:
▶ Pharma Tech Outlook APAC (Digital Edition)
▶ Pharma Tech Outlook APAC (Web Edition)
▶ Top Drug Discovery and Development Solutions in APAC
■ Pharma Tech Outlook APAC
Pharma Tech Outlook APAC is an industry publication that showcases the latest trends and advanced solutions in the pharmaceutical, biotechnology, and healthcare sectors across the Asia-Pacific region. It provides executives and industry professionals with insights into the latest news, market trends, and technological innovations, with approximately 78,000 copies distributed worldwide each month.